U.S. Markets
US PRE-MARKET MOVERS: AZN, CIBR, U, AGX, TRIP
News detail
ES -0.4% NQ -0.6% RTY -0.6% AZN +3.6%: Tozorakimab met primary endpoint in both OBERON and TITANIA Phase III trials CIBR -2.4%: Reports emerge of leaked Anthropic AI model, "Claude Mythos"; co. believes it poses unprecedented cybersecurity risks U +14.1%: Raised Q1 revenue view; PT raised at BofA AGX +9.5%: Earnings beat; upgraded at JPM to 'Overweight' from 'Neutral' TRIP +3.8%: Upgraded at BofA to 'Buy' from 'Neutral'
Related stocks
5 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
